Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Margaret G Mcglynn. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Margaret G Mcglynn har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:NVAX / Novavax, Inc. Director 25.588
US:FOLD / Amicus Therapeutics, Inc. Director 91.550
US:VRTX / Vertex Pharmaceuticals Incorporated Director 4.462
US:APD / Air Products and Chemicals, Inc. Director 42.814
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Margaret G Mcglynn. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb FOLD / Amicus Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i FOLD / Amicus Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2015-11-10 FOLD MCGLYNN MARGARET G 10.000 10,2657 10.000 10,2657 102.657 17 11.53 12.643 12,32

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

FOLD / Amicus Therapeutics, Inc. Insider Trades
Insidersalg FOLD / Amicus Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i FOLD / Amicus Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2024-03-05 FOLD MCGLYNN MARGARET G 7.500 13,4000 7.500 13,4000 100.500 311 9.0200 -32.850 -32,69
2024-03-04 FOLD MCGLYNN MARGARET G 7.500 13,2900 7.500 13,2900 99.675

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

FOLD / Amicus Therapeutics, Inc. Insider Trades
Insiderkøb NVAX / Novavax, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i FOLD / Amicus Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

NVAX / Novavax, Inc. Insider Trades
Insidersalg NVAX / Novavax, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i FOLD / Amicus Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

NVAX / Novavax, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Margaret G Mcglynn som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-06-16 2025-06-12 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 10.420 25.588 68,70
2025-06-06 2025-06-05 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 20.414 91.550 28,70
2025-02-05 2024-12-31 4 NVAX NOVAVAX INC
Common Stock
A - Award 1.178 15.168 8,42 8,61 10.143 130.596
2025-02-05 2024-09-30 4 NVAX NOVAVAX INC
Common Stock
A - Award 778 13.990 5,89 12,77 9.935 178.652
2025-02-05 2024-06-30 4 NVAX NOVAVAX INC
Common Stock
A - Award 713 13.212 5,70 13,93 9.932 184.043
2025-02-05 2024-03-31 4 NVAX NOVAVAX INC
Common Stock
A - Award 2.029 5.829 53,39 4,90 9.942 28.562
2024-06-14 2024-06-12 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 6.670 10.470 175,53
2024-06-07 2024-06-06 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 11.847 71.136 19,98
2024-03-06 2024-03-05 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale -7.500 59.289 -11,23 13,40 -100.500 794.473
2024-03-06 2024-03-05 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 7.500 66.789 12,65 2,80 21.000 187.009
2024-03-06 2024-03-04 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale -7.500 59.289 -11,23 13,29 -99.675 787.951
2024-03-06 2024-03-04 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 7.500 66.789 12,65 2,80 21.000 187.009
2023-06-13 2023-06-10 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 3.100 3.800 442,86
2023-06-12 2023-06-08 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 8.584 59.289 16,93
2023-01-17 2023-01-13 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale X -15.000 50.705 -22,83 13,03 -195.387 660.473
2023-01-17 2023-01-13 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 15.000 65.705 29,58 3,32 49.800 218.141
2022-06-21 2022-06-17 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 700 700
2022-06-10 2022-06-09 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 12.671 50.705 33,31
2022-05-04 2022-05-02 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
D - Sale to Issuer -15.000 0 -100,00
2022-05-04 2022-05-02 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale X -15.000 38.034 -28,28 6,99 -104.896 265.976
2022-05-04 2022-05-02 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 15.000 53.034 39,44 4,79 71.850 254.033
2022-05-03 2022-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 4.462 4.462
2022-05-03 2022-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 921 5.609 19,65
2022-05-03 2022-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
D - Sale to Issuer -921 178 -83,80
2022-04-12 2022-04-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -5.000 5.000 -50,00
2022-04-12 2022-04-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 1.099 -8,34 281,49 -28.149 309.358
2022-04-12 2022-04-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.900 1.199 -80,34 280,19 -1.372.931 335.948
2022-04-12 2022-04-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 5.000 6.099 454,96 127,54 637.700 777.866
2022-04-04 2022-03-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock (right to buy)
M - Exercise -5.000 10.000 -33,33 127,54 -637.700 1.275.400
2022-04-04 2022-03-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.011 1.099 -47,91 262,97 -265.863 289.004
2022-04-04 2022-03-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.970 2.110 -58,46 262,37 -779.239 553.601
2022-04-04 2022-03-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.019 5.080 -16,71 261,28 -266.244 1.327.302
2022-04-04 2022-03-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 5.000 6.099 454,96 127,54 637.700 777.866
2022-02-01 2022-01-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -5.000 15.000 -25,00 127,54 -637.700 1.913.100
2022-02-01 2022-01-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -212 1.099 -16,17 243,24 -51.567 267.321
2022-02-01 2022-01-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.087 1.311 -61,42 242,78 -506.682 318.285
2022-02-01 2022-01-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -800 3.398 -19,06 241,83 -193.464 821.738
2022-02-01 2022-01-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.901 4.198 -31,17 240,53 -457.248 1.009.745
2022-02-01 2022-01-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 5.000 6.099 454,96 127,54 637.700 777.866
2021-06-22 2021-06-17 4 NVAX NOVAVAX INC
Restricted Stock Units
A - Award 700 700
2021-06-22 2021-06-17 4 NVAX NOVAVAX INC
Stock Option (Right to Buy)
A - Award 1.300 1.300
2021-06-14 2021-06-10 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
A - Award 36.111 36.111
2021-06-14 2021-06-10 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 10.115 38.034 36,23
2021-06-03 2021-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 699 4.688 17,52
2021-06-03 2021-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
D - Sale to Issuer -699 1.099 -38,88
2021-05-05 2021-05-03 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
M - Exercise -10.000 0 -100,00
2021-05-05 2021-05-03 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 27.919 -26,37 10,27 -102.704 286.739
2021-05-05 2021-05-03 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 10.000 37.919 35,82 7,51 75.100 284.772
2021-05-04 2021-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 3.034 3.034
2021-05-04 2021-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 921 1.798 105,02
2020-12-09 2020-12-07 4 NVAX NOVAVAX INC
Stock Option (Right to buy)
A - Award 7.700 7.700
2020-10-01 2020-09-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 194 42.814 0,46 293,86 57.110 12.581.213
2020-08-26 2020-08-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
G - Gift -3.707 877 -80,87
2020-07-02 2020-06-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 238 42.619 0,56 238,61 56.791 10.169.388
2020-06-08 2020-06-04 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
A - Award 18.574 18.574
2020-06-08 2020-06-04 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 5.855 27.919 26,54
2020-06-03 2020-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 2.264 2.264
2020-06-03 2020-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 699 4.584 17,99
2020-04-20 2020-04-17 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
M - Exercise -10.000 0 -100,00
2020-04-20 2020-04-17 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 22.064 -31,19 11,00 -110.000 242.704
2020-04-20 2020-04-17 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 10.000 32.064 45,32 2,81 28.100 90.100
2020-04-02 2020-03-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 237 42.381 0,56 206,53 48.888 8.753.005
2020-01-24 2020-01-23 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 630 42.145 1,52 238,04 150.000 10.032.093
2020-01-10 2020-01-09 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
M - Exercise -20.000 0 -100,00
2020-01-10 2020-01-09 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale X -20.000 22.064 -47,55 10,00 -200.000 220.640
2020-01-10 2020-01-09 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 20.000 42.064 90,65 3,32 66.400 139.652
2020-01-03 2019-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 204 41.514 0,49 235,33 47.921 9.769.589
2019-11-27 2019-11-26 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 3.973 41.311 10,64
2019-11-20 2019-11-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
G - Gift -239 3.885 -5,80
2019-10-24 2019-10-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -20.000 0 -100,00
2019-10-24 2019-10-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -20.000 4.124 -82,90 190,00 -3.800.000 783.560
2019-10-24 2019-10-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 20.000 24.124 484,97 72,14 1.442.800 1.740.305
2019-10-02 2019-09-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 199 37.246 0,54 221,86 44.255 8.263.348
2019-08-15 2019-08-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise 10.000 0 -100,00
2019-08-15 2019-08-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10.000 4.124 -70,80 185,00 -1.850.000 762.940
2019-08-15 2019-08-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10.000 14.124 242,48 81,54 815.400 1.151.671
2019-07-02 2019-07-01 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 195 37.046 0,53 226,37 44.029 8.386.172
2019-07-01 2019-06-27 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
A - Award 19.473 19.473
2019-07-01 2019-06-27 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 6.250 22.064 39,52
2019-06-04 2019-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 1.801 3.989 82,31
2019-06-04 2019-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 6.659 6.659
2019-06-04 2019-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
D - Sale to Issuer -1.801 4.124 -30,40
2019-04-02 2019-04-01 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 217 36.852 0,59 186,51 40.532 6.873.230
2019-01-25 2019-01-24 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 952 36.634 2,67 157,71 150.140 5.777.625
2019-01-02 2018-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 256 35.682 0,72 156,92 40.250 5.599.296
2018-10-01 2018-09-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 236 35.426 0,67 167,80 39.669 5.944.481
2018-07-02 2018-06-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 254 35.190 0,73 155,16 39.390 5.460.015
2018-06-11 2018-06-07 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 8.912 8.912
2018-06-11 2018-06-07 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
A - Award 3.081 8.895 52,99
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 2.188 2.188
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 3.229 3.229
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
D - Sale to Issuer -2.188 5.925 -26,97
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 1.801 8.113 28,53
2018-05-18 2018-05-16 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
M - Exercise -10.000 20.000 -33,33
2018-05-18 2018-05-16 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
S - Sale X -10.000 15.814 -38,74 16,00 -160.000 253.024
2018-05-18 2018-05-16 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
M - Exercise 10.000 25.814 63,24 3,32 33.200 85.702
2018-04-03 2018-03-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 208 34.936 0,60 158,18 32.972 5.526.131
2018-03-05 2018-03-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -10.000 10.000 -50,00
2018-03-05 2018-03-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10.000 6.312 -61,30 170,00 -1.700.000 1.073.040
2018-03-05 2018-03-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10.000 16.312 158,43 81,54 815.400 1.330.080
2018-01-29 2018-01-25 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 863 34.727 2,55 174,00 150.162 6.042.545
2018-01-24 2018-01-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -10.000 0 -100,00
2018-01-24 2018-01-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10.000 6.217 -61,66 165,00 -1.650.000 1.025.805
2018-01-24 2018-01-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10.000 16.217 160,85 59,55 595.500 965.722
2018-01-24 2018-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -10.000 10.000 -50,00
2018-01-24 2018-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10.000 6.217 -61,66 160,00 -1.600.000 994.720
2018-01-24 2018-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10.000 16.217 160,85 59,55 595.500 965.722
2018-01-02 2017-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 200 33.864 0,59 163,67 32.781 5.542.565
2017-10-02 2017-09-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 215 33.664 0,64 151,32 32.577 5.094.033
2017-07-05 2017-06-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 223 33.449 0,67 144,84 32.365 4.844.709
2017-06-16 2017-06-13 4/A FOLD AMICUS THERAPEUTICS INC
Common Stock
A - Award 5.814 15.814 58,14
2017-06-15 2017-06-13 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 16.236 16.236
2017-06-15 2017-06-13 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
A - Award 5.814 5.814
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise 5.295 5.295
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 2.188 6.217 54,31
2017-04-04 2017-03-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 203 33.225 0,61 136,78 27.706 4.544.549
2017-01-27 2017-01-26 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 807 33.023 2,50 148,81 120.090 4.914.106
2017-01-04 2016-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 190 32.216 0,59 145,12 27.542 4.675.141
2016-09-30 2016-09-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 183 32.026 0,57 149,78 27.385 4.796.839
2016-07-05 2016-06-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 199 31.843 0,63 136,55 27.180 4.348.170
2016-06-13 2016-06-09 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 20.000 20.000
2016-06-03 2016-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 7.073 7.073
2016-06-03 2016-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 2.941 4.029 270,31 0,01 29 40
2016-04-25 2016-03-31 4/A APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 170 31.644 0,54 145,03 24.677 4.589.331
2016-03-31 2016-03-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 343 31.816 1,09 145,03 49.677 4.614.331
2016-01-29 2016-01-28 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 1.009 31.474 3,31 119,01 120.081 3.745.705
2016-01-05 2015-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 401 30.465 1,33 133,20 53.352 4.057.920
2015-11-20 2015-11-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -12.500 0 -100,00
2015-11-20 2015-11-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -12.500 1.088 -91,99 130,15 -1.626.875 141.603
2015-11-20 2015-11-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 12.500 13.588 1.148,90 57,27 715.875 778.185
2015-11-10 2015-11-10 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
P - Purchase 10.000 10.000 10,27 102.657 102.657
2015-09-30 2015-09-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 439 30.064 1,48 125,25 54.996 3.765.557
2015-08-05 2015-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise 12.500 12.500
2015-08-05 2015-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 1.088 -8,42 138,98 -13.898 151.210
2015-08-05 2015-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.700 1.188 -69,44 138,22 -373.194 164.205
2015-08-05 2015-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6.500 3.888 -62,57 137,26 -892.190 533.667
2015-08-05 2015-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.200 10.388 -23,55 136,49 -436.768 1.417.858
2015-08-05 2015-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 12.500 13.588 1.148,90 57,27 715.875 778.185
2015-06-30 2015-06-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 388 29.625 1,33 142,08 55.182 4.209.153
2015-06-12 2015-06-10 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 20.000 20.000
2015-06-03 2015-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise 7.500 0 -100,00
2015-06-03 2015-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise 5.000 25.000 25,00
2015-06-03 2015-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 20.000 20.000
2015-06-03 2015-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -9.020 1.088 -89,24 127,53 -1.150.321 138.753
2015-06-03 2015-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.480 10.108 -25,61 126,78 -441.194 1.281.492
2015-06-03 2015-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 7.500 13.588 123,19 53,85 403.875 731.714
2015-06-03 2015-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 5.000 6.088 459,56 57,27 286.350 348.660
2015-04-08 2015-04-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 12.500 7.500 -250,00
2015-04-08 2015-04-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -400 1.088 -26,88 119,78 -47.912 130.321
2015-04-08 2015-04-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.900 1.488 -72,38 118,97 -463.983 177.027
2015-04-08 2015-04-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6.000 5.388 -52,69 118,32 -709.920 637.508
2015-04-08 2015-04-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.200 11.388 -16,19 117,14 -257.708 1.333.990
2015-04-08 2015-04-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 12.500 13.588 1.148,90 53,85 673.125 731.714
2015-03-31 2015-03-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 369 29.237 1,28 152,75 56.338 4.465.928
2015-02-13 2012-08-10 5 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 15 1.088 1,40 51,23 768 55.738
2015-02-13 2011-12-07 5 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 9 1.088 0,83 29,19 263 31.759
2015-02-13 2011-12-06 5 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 33 1.088 3,13 29,66 979 32.270
2015-02-13 2011-11-22 5 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 31 1.088 2,93 28,00 868 30.464
2015-01-23 2015-01-22 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 832 28.868 2,97 144,32 120.074 4.166.233
2015-01-05 2014-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 353 28.036 1,27 147,57 52.066 4.137.276
2014-09-30 2014-09-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 414 27.683 1,52 134,77 55.748 3.730.865
2014-06-30 2014-06-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 415 27.270 1,54 128,83 53.428 3.513.136
2014-06-16 2014-06-12 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 15.000 15.000
2014-06-03 2014-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 20.000 20.000
2014-04-01 2014-03-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 445 26.855 1,69 118,44 52.733 3.180.686
2014-01-24 2014-01-23 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 1.081 26.410 4,27 111,01 120.002 2.931.730
2014-01-03 2013-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 452 25.329 1,82 113,43 51.326 2.873.023
2013-09-30 2013-09-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 465 24.876 1,91 109,78 51.082 2.730.899
2013-07-01 2013-06-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 445 24.411 1,86 96,13 42.766 2.346.610
2013-06-17 2013-06-13 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 15.000 15.000
2013-06-04 2013-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 20.000 20.000
2013-04-01 2013-03-29 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 486 23.966 2,07 86,28 41.906 2.067.780
2013-01-25 2013-01-24 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 1.361 23.480 6,15 88,23 120.081 2.071.660
2013-01-02 2012-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 483 22.119 2,23 84,80 40.955 1.875.710
2012-11-08 2012-11-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 1.000 1.000 45,50 45.500 45.500
2012-10-01 2012-09-28 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 496 21.636 2,35 83,18 41.280 1.799.704
2012-07-02 2012-06-29 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 509 21.140 2,47 76,56 38.954 1.618.478
2012-06-15 2012-06-13 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 15.000 15.000
2012-06-01 2012-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 20.000 20.000
2012-03-30 2012-03-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 458 20.631 2,27 90,49 41.411 1.866.917
2012-01-27 2012-01-26 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 1.362 20.174 7,24 88,16 120.074 1.778.501
2012-01-04 2011-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 408 18.812 2,22 84,98 34.674 1.598.607
2011-05-13 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
0
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)